Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Oncol. Apr 15, 2022; 14(4): 897-919
Published online Apr 15, 2022. doi: 10.4251/wjgo.v14.i4.897
Table 4 Prognostic factors of patients with gastric cancer by univariate and multivariate analyses based on logistic regression analysis in the intermediate type group
Characteristics
INFb
Univariate analysis
Multivariate analysis
HR (95%CI)
P value
HR (95%CI)
P value
Sex0.115
Male1
Female0.617 (0.339-1.124)
Age (yr)1.033 (1.007-1.061)0.0141.036 (1.004-1.069)0.026
BMI0.814 (0.746-0.888)< 0.0010.861 (0.781-0.950)0.003
PLR1.008 (1.003-1.012)< 0.0011.006 (1.001-1.012)0.018
ALT0.976 (0.949-1.004)0.094
Total protein0.975 (0.946-1.004)0.092
CEA1.004 (0.995-1.014)0.338
CA19-91.003 (1.001-1.006)0.0121.000 (0.998-1.003)0.650
Borrmann type0.0050.226
0-111
21.031 (0.430-2.473)0.9450.715 (0.246-2.079)0.538
32.410 (1.081-5.372)0.0311.530 (0.554-4.223)0.412
4-53.182 (1.201-8.429)0.0201.339 (0.374-4.797)0.654
Tumor location0.088--
Lower third1
Middle third1.195 (0.641-2.228)0.575
Upper third1.527 (0.697-3.345)0.290
Entire stomach7.634 (1.441-40.446)0.017
Tumor size (mm)1.021 (1.012-1.032)< 0.0011.007 (0.994-1.021)0.302
pTNM stage< 0.001< 0.001
I11
II3.929 (1.120-13.785)0.0332.036 (0.528-7.856)0.302
III23.010 (6.895-76.795)< 0.0018.306 (2.053-33.597)0.003
Histological types0.739
Well and medium differentiation1
Poor differentiation1.105 (0.617-1.977)0.738
Others0.853 (0.472-1.542)0.599
mLNR87.343 (18.612-409.881)< 0.0012.267 (0.291-17.641)0.434
Vascular infiltration< 0.0010.149
No11
Yes3.160 (1.897-5.263)1.585 (0.848-2.963)
Nerve infiltration0.0030.859
No11
Yes2.097 (1.283-3.428)1.057 (0.573-1.951)
Postoperative chemotherapy0.493
Yes1
No0.823 (0.472-1.436)